Juan Cen

1.3k total citations
53 papers, 1.0k citations indexed

About

Juan Cen is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Juan Cen has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Neurology. Recurrent topics in Juan Cen's work include Drug Transport and Resistance Mechanisms (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neurological Disease Mechanisms and Treatments (6 papers). Juan Cen is often cited by papers focused on Drug Transport and Resistance Mechanisms (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers) and Neurological Disease Mechanisms and Treatments (6 papers). Juan Cen collaborates with scholars based in China, Hong Kong and Taiwan. Juan Cen's co-authors include Bian‐Sheng Ji, Yun Zhang, Zhili Jia, Yunman Li, Feng Zhang, Weirong Fang, Chung‐Der Hsiao, Shaofeng Duan, Qing Xia and Xiqiang Chen and has published in prestigious journals such as Chemical Engineering Journal, ACS Applied Materials & Interfaces and Chemosphere.

In The Last Decade

Juan Cen

50 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Juan Cen China 19 334 162 156 104 92 53 1.0k
Yu‐Wen Cheng Taiwan 24 585 1.8× 103 0.6× 144 0.9× 126 1.2× 185 2.0× 71 1.5k
Uhee Jung South Korea 22 703 2.1× 71 0.4× 161 1.0× 167 1.6× 55 0.6× 76 1.8k
Yuqin Zhang China 22 751 2.2× 295 1.8× 100 0.6× 80 0.8× 37 0.4× 88 1.6k
Yihao Zhu China 21 560 1.7× 99 0.6× 125 0.8× 108 1.0× 140 1.5× 50 1.2k
Noriko Fujiwara Japan 24 652 2.0× 106 0.7× 64 0.4× 114 1.1× 71 0.8× 51 1.8k
Ahmed S. Ibrahim Egypt 21 487 1.5× 253 1.6× 46 0.3× 96 0.9× 27 0.3× 64 1.5k
Shohda A. El‐Maraghy Egypt 20 421 1.3× 50 0.3× 83 0.5× 115 1.1× 103 1.1× 40 1.1k
Jiangzheng Liu China 19 575 1.7× 69 0.4× 67 0.4× 116 1.1× 84 0.9× 35 1.1k
Tiantian Guo China 18 687 2.1× 151 0.9× 197 1.3× 141 1.4× 29 0.3× 74 1.5k

Countries citing papers authored by Juan Cen

Since Specialization
Citations

This map shows the geographic impact of Juan Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Cen more than expected).

Fields of papers citing papers by Juan Cen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Cen. The network helps show where Juan Cen may publish in the future.

Co-authorship network of co-authors of Juan Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Cen. A scholar is included among the top collaborators of Juan Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Cen. Juan Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaohan, Han Zhao, Jing Wu, et al.. (2025). Folate receptor-targeted pH-sensitive liposomes loaded with TGX-221 against prostate cancer by inhibiting PI3K/110β signaling. Nanoscale Advances. 7(11). 3267–3280. 1 indexed citations
2.
Cen, Juan, Ping Lu, Chenwei Wang, et al.. (2025). Double Swords in One: Novel Selective PI3K/110β PROTAC Degraders for the Treatment of Multidrug-Resistant Cancer by Activating ERS and Inhibiting P-gp. Journal of Medicinal Chemistry. 68(9). 9446–9464.
3.
Zhang, Yumei, et al.. (2025). Exosomes-encapsulated biomimetic polydopamine carbon dots with dual-targeting effect alleviate motor and non-motor symptoms of Parkinson's disease via anti-neuroinflammation. International Journal of Biological Macromolecules. 296. 139724–139724. 6 indexed citations
4.
He, Yu, Jinpeng Liu, Juan Cen, et al.. (2025). Weak Measurement of the Angular Goos-Hänchen Shift from a Monolayer MoS2 Immersed in a Dielectric Medium. ACS Photonics. 12(2). 1022–1029. 1 indexed citations
5.
Hu, Peng, Xiaowen Peng, Shuang Zhao, et al.. (2024). Self-sacrificed construction of versatile nanoadjuvant for synergistically enhanced immunogenic cell death and improved anti-tumor immunity. Chemical Engineering Journal. 492. 152033–152033. 5 indexed citations
6.
Duan, Sijing, Feng Lyu, Juan Cen, et al.. (2024). Flexible and Effective Cellular Traffic Data Synthesis with Large Language Model. 5223–5228. 1 indexed citations
7.
Wang, Ruijiao, Wei Liu, Lu Liu, et al.. (2023). Characterization, in vitro digestibility, antioxidant activity and intestinal peristalsis in zebrafish of Dioscorea opposita polysaccharides. International Journal of Biological Macromolecules. 250. 126155–126155. 18 indexed citations
8.
Cen, Juan, et al.. (2023). Doxorubicin-Loaded Liposome with the Function of “Killing Two Birds with One Stone” against Glioma. ACS Applied Materials & Interfaces. 15(40). 46697–46709. 15 indexed citations
10.
Duan, Shaofeng, Yifan Xia, Xue Tian, et al.. (2023). A multi-bioresponsive self-assembled nano drug delivery system based on hyaluronic acid and geraniol against liver cancer. Carbohydrate Polymers. 310. 120695–120695. 39 indexed citations
11.
Duan, Shaofeng, Mengmeng Zhang, Qian Dong, et al.. (2023). A Water-Soluble Hydrogen Sulfide Donor Suppresses the Growth of Hepatocellular Carcinoma via Inhibiting the AKT/GSK-3β/β-Catenin and TGF-β/Smad2/3 Signaling Pathways. Journal of Oncology. 2023. 1–17. 11 indexed citations
12.
Cen, Juan, et al.. (2022). Research progress of stem cell therapy for endometrial injury. Materials Today Bio. 16. 100389–100389. 41 indexed citations
13.
Zhang, Yun, et al.. (2021). Curcumin Derivative Cur20 Attenuated Cerebral Ischemic Injury by Antioxidant Effect and HIF-1α/VEGF/TFEB-Activated Angiogenesis. Frontiers in Pharmacology. 12. 648107–648107. 15 indexed citations
14.
Zhang, Yun, Zhili Jia, Chengyue Zhu, et al.. (2021). Exposure of particulate matter (PM10) induces neurodevelopmental toxicity in zebrafish embryos. NeuroToxicology. 87. 208–218. 14 indexed citations
15.
Wang, Fei, et al.. (2020). HMGB1 promoted P-glycoprotein at the blood-brain barrier in MCAO rats via TLR4/NF-κB signaling pathway. European Journal of Pharmacology. 880. 173189–173189. 27 indexed citations
16.
Jia, Zhili, Juan Cen, Jiabo Wang, et al.. (2019). Mechanism of isoniazid-induced hepatotoxicity in zebrafish larvae: Activation of ROS-mediated ERS, apoptosis and the Nrf2 pathway. Chemosphere. 227. 541–550. 118 indexed citations
18.
Wang, Jianhong, Lu Liu, Juan Cen, & Bian‐Sheng Ji. (2015). BME, a novel compound of anthraquinone, down regulated P-glycoprotein expression in doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells via generation of reactive oxygen species. Chemico-Biological Interactions. 239. 139–145. 8 indexed citations
19.
Xiong, Jing, Li Bai, Wei Fang, et al.. (2012). New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation. European Journal of Pharmaceutical Sciences. 45(5). 552–558. 11 indexed citations
20.
Deng, Yan, Weirong Fang, Yunman Li, et al.. (2009). Blood-brain barrier breakdown by PAF and protection by XQ-1H due to antagonism of PAF effects. European Journal of Pharmacology. 616(1-3). 43–47. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026